This strategic collaboration brings together Syngene’s integrated drug discovery (IDD) services and skills of Deerfield’s drug discovery and development arm 3DC. 

With execution of share purchase agreement and completion of sale November 18, 2020, GTPL Space City has ceased as subsidiary of the company.

With extensive reach, partnership and network with the public health authorities and other institutions, Cipla will be ensure uninterrupted access of these kits across more than 25 markets in Asia, Australia, Europe, Middle East, North Africa and Latin America.

The strategic collaboration includes software development and integration. It also covers maintenance of the combined powertrain coordination units including charging control.

Blue Star Limited is experiencing a gradual increase in the inflow of orders for bundled services. Presently, this order is one of the largest and fast-track projects, which is being executed by Blue Star in the factories’ segment.

The mineable reserve block is 1,091 million metric tonnes, which is to be exploited for a period of 25 years at a peak rated capacity of 50 million tonnes per annum.

The MoU would help to create a market for pre-engineered steel buildings made from structural steel tubes, which is consistent with APL’s strategy to create new markets for structural steel tubes in India.  

The yearly business from the new US customer is expected to realise approximately USD 10 million in the current financial year.The new business relationship will support the company in maintaining full capacity production at its Chennai steel wheels’ plant.

With this partnership, Dr Reddy’s Laboratories can identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under National Biopharma Mission (NBM) at BIRAC.

Under this collaboration, TCS will help Equinor to speed up its digitalisation process and enable it realise the vision of becoming a digital energy company.